Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen

American Journal of Physiology - Heart and Circulatory Physiology - Tập 296 Số 6 - Trang H1888-H1897 - 2009
Arsalan Shabbir1, David Zisa, Gen Suzuki, Techung Lee
1Department of Biochemistry and Center for Research in Cardiovascular Medicine, University at Buffalo, Buffalo, NY 14214, USA.

Tóm tắt

Heart failure carries a poor prognosis with few treatment options. While myocardial stem cell therapeutic trials have traditionally relied on intracoronary infusion or intramyocardial injection routes, these cell delivery methods are invasive and can introduce harmful scar tissue, arrhythmia, calcification, or microinfarction in the heart. Given that patients with heart failure are at an increased surgical risk, the development of a noninvasive stem cell therapeutic approach is logistically appealing. Taking advantage of the trophic effects of bone marrow mesenchymal stem cells (MSCs) and using a hamster heart failure model, the present study demonstrates a novel noninvasive therapeutic regimen via the direct delivery of MSCs into the skeletal muscle bed. Intramuscularly injected MSCs and MSC-conditioned medium each significantly improved ventricular function 1 mo after MSC administration. MSCs at 4 million cells/animal increased fractional shortening by ∼40%, enhanced capillary and myocyte nuclear density by ∼30% and ∼80%, attenuated apoptosis by ∼60%, and reduced fibrosis by ∼50%. Myocyte regeneration was evidenced by an approximately twofold increase in the expression of cell cycle markers (Ki67 and phosphohistone H3) and an ∼13% reduction in mean myocyte diameter. Increased circulating levels of hepatocyte growth factor (HGF), leukemia inhibitory factor, and macrophage colony-stimulating factor were associated with the mobilization of c-Kit-positive, CD31-positive, and CD133-positive progenitor cells and a subsequent increase in myocardial c-Kit-positive cells. Trophic effects of MSCs further activated the expression of HGF, IGF-II, and VEGF in the myocardium. The work highlights a cardiac repair mechanism mediated by trophic cross-talks among the injected MSCs, bone marrow, and heart that can be explored for noninvasive stem cell therapy.

Từ khóa


Tài liệu tham khảo

10.1002/jcb.10594

10.1161/01.CIR.0000084828.50310.6A

10.1073/pnas.0706760104

Brann WM, Bennett LE, Keck BM, Hosenpud JD. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant 17: 374–382, 1998.

10.1182/blood-2006-12-063412

10.1001/jama.299.8.925

10.1002/jcb.20886

10.1084/jem.20070166

10.1083/jcb.200212064

10.1126/science.1110364

10.1006/jmcc.1997.0420

10.1002/path.1717

10.1002/jcp.20959

10.1096/fj.05-5211com

10.1161/CIRCRESAHA.108.176826

10.1139/y01-003

10.1097/01.tp.0000269200.67707.c8

10.1074/jbc.274.36.25543

10.1161/CIRCRESAHA.108.186742

10.1161/CIRCULATIONAHA.107.758904

10.1016/S1050-1738(03)00077-X

10.1161/CIRCULATIONAHA.105.541433

10.1016/j.bbrc.2004.09.049

10.1161/01.RES.86.12.1198

10.1007/s00395-008-0742-z

10.1016/j.jacc.2007.01.095

10.1016/j.athoracsur.2007.03.052

Korbling M. In vivo expansion of the circulating stem cell pool. Stem Cells 16, Suppl 1: 131–138, 1998.

10.1038/sj.leu.2404011

10.1016/S0092-8674(02)01078-4

10.1161/01.RES.0000238375.88582.d8

10.3727/096368908786576444

10.1136/jcp.45.5.416

10.1002/jcp.21414

10.1089/scd.2006.0118

10.1161/01.CIR.98.25.2800

10.1161/CIRCULATIONAHA.106.681866

10.1016/S0735-1097(03)00092-5

10.1007/s11010-008-9908-0

10.1152/ajpheart.01071.2003

10.1152/ajpheart.01239.2003

10.1038/35070587

10.1016/j.ejheart.2008.08.002

10.1007/s395-002-8389-4

10.1073/pnas.94.25.13873

10.1038/nature06800

10.1007/s00395-004-0506-3

Shabbir A, Zisa D, Leiker M, Johnston C, Lin H, Lee T. Muscular dystrophy therapy by non-autologous mesenchymal stem cells: muscle regeneration without immunosuppression and inflammation. Transplantation. In press.

10.1161/01.CIR.102.16.1944

10.1161/01.RES.0000162099.01268.d1

10.1152/ajpheart.00142.2006

10.1016/j.athoracsur.2005.02.072

10.1161/01.RES.0000219901.13974.15

10.1038/nature730

10.1152/ajprenal.00007.2005

10.1186/ar2103

10.1161/01.RES.0000225952.61196.39

10.1002/jcp.20376

10.1016/S0140-6736(04)15695-X

10.1016/j.ijcard.2005.09.055

10.1161/01.CIR.0000134696.08436.65

10.1161/01.CIR.0000081773.76337.44

Thông tin
Thông tin xuất bản

American Journal of Physiology - Heart and Circulatory Physiology

Tập 296 Số 6

H1888-H1897

Thông tin tác giả